Abstract
Liver resection remains to be the curative treatment of choice for both malignant and benign liver tumors. With advances in hepatic surgery and operative technique, liver resection has evolved from a rough and hasty procedure to a fine and delicate operation. Such surgical advances have resulted in a dramatic reduction of operative mortality, from over 50 % in early series [1] to less than 10 % in recent decades [2–4], and targeting “zero” mortality has even become a realistic goal to achieve [5]. However, the postoperative complication rate remains largely unchanged over the years despite a reduction in operative mortality and is in the range of 20–30 %. Liver failure, bile leakage, and sepsis are serious complications that can lead to a fatal outcome. In this chapter, we will present our approach for prevention, diagnosis, and management of these complications.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Foster JH, Berman MM. Solid liver tumors. Major Probl Clin Surg. 1977;22:89.
Belghiti J, et al. A ten-year experience with hepatic resection in 338 patients: evolutions in indications and of operative mortality. Eur J Surg. 1994;160(5):277–82.
Vauthey, J.N., et al., Factors affecting long-term outcome after hepatic resection for hepatocellular carcinoma. Am J Surg. 1995; 169(1): 28–34; discussion 34–5.
Segawa, T., et al., Operative results in 143 patients with hepatocellular carcinoma. World J Surg. 1993; 17(5): 663–7; discussion 668.
Fan ST, et al. Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths. Ann Surg. 1999;229(3):322–30.
Miyagawa S, et al. Criteria for safe hepatic resection. Am J Surg. 1995;169(6):589–94.
Wei AC, et al. Risk factors for perioperative morbidity and mortality after extended hepatectomy for hepatocellular carcinoma. Br J Surg. 2003;90(1):33–41.
Schroeder RA, et al. Predictive indices of morbidity and mortality after liver resection. Ann Surg. 2006;243(3):373–9.
Ichikawa T, et al. A simple, noninvasively determined index predicting hepatic failure following liver resection for hepatocellular carcinoma. J Hepatobiliary Pancreat Surg. 2009;16(1):42–8.
Fan ST. Liver functional reserve estimation: state of the art and relevance for local treatments: the Eastern perspective. J Hepatobiliary Pancreat Sci. 2010;17(4):380–4.
Lo CM, et al. Minimum graft volume for successful adult-to-adult living donor liver transplantation for fulminant hepatic failure. Transplantation. 1996;62(5):696–8.
Abdalla EK, Hicks ME, Vauthey JN. Portal vein embolization: rationale, technique and future prospects. Br J Surg. 2001;88(2):165–75.
Hemming, A.W., et al., Preoperative portal vein embolization for extended hepatectomy. Ann Surg. 2003; 237(5): 686–91; discussion 691–3.
Liu CL, et al. Anterior approach versus conventional approach right hepatic resection for large hepatocellular carcinoma: a prospective randomized controlled study. Ann Surg. 2006;244(2):194–203.
Jones RM, Moulton CE, Hardy KJ. Central venous pressure and its effect on blood loss during liver resection. Br J Surg. 1998;85(8):1058–60.
Ryu HG, et al. Low central venous pressure with milrinone during living donor hepatectomy. Am J Transplant. 2010;10(4):877–82.
Man, K., et al., Prospective evaluation of Pringle maneuver in hepatectomy for liver tumors by a randomized study. Ann Surg. 1997; 226(6): 704–11; discussion 711–3.
Fan ST. Protection of the liver during partial hepatectomy. Hepatobiliary Pancreat Dis Int. 2004;3(4):490–4.
Fan ST, et al. Perioperative nutritional support in patients undergoing hepatectomy for hepatocellular carcinoma. N Engl J Med. 1994;331(23):1547–52.
Wauters J, Wilmer A. Albumin dialysis: current practice and future options. Liver Int. 2011;31 Suppl 3:9–12.
Chiu A, Chan LM, Fan ST. Molecular adsorbent recirculating system treatment for patients with liver failure: the Hong Kong experience. Liver Int. 2006;26(6):695–702.
Lo CM, et al. Biliary complications after hepatic resection: risk factors, management, and outcome. Arch Surg. 1998;133(2):156–61.
Yamashita Y, et al. Bile leakage after hepatic resection. Ann Surg. 2001;233(1):45–50.
Nagano Y, et al. Risk factors and management of bile leakage after hepatic resection. World J Surg. 2003;27(6):695–8.
Calandra T, et al. Prognostic values of tumor necrosis factor/cachectin, interleukin-1, interferon-alpha, and interferon-gamma in the serum of patients with septic shock. Swiss-Dutch J5 immunoglobulin study group. J Infect Dis. 1990;161(5):982–7.
Calandra T, et al. High circulating levels of interleukin-6 in patients with septic shock: evolution during sepsis, prognostic value, and interplay with other cytokines. The Swiss-Dutch J5 immunoglobulin study group. Am J Med. 1991;91(1):23–9.
Martin C, et al. Patterns of cytokine evolution (tumor necrosis factor-alpha and interleukin-6) after septic shock, hemorrhagic shock, and severe trauma. Crit Care Med. 1997;25(11):1813–9.
Martin C, et al. Prognostic values of serum cytokines in septic shock. Intensive Care Med. 1994;20(4):272–7.
Lam CM, et al. Biliary complications during liver resection. World J Surg. 2001;25(10):1273–6.
Yanaga K, et al. Intraperitoneal septic complications after hepatectomy. Ann Surg. 1986;203(2):148–52.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media New York
About this chapter
Cite this chapter
Chan, A.C.Y., Fan, S.T. (2012). Liver Surgery: Early Complications—Liver Failure, Bile Leak, and Sepsis. In: Wagener, G. (eds) Liver Anesthesiology and Critical Care Medicine. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-5167-9_37
Download citation
DOI: https://doi.org/10.1007/978-1-4614-5167-9_37
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-5166-2
Online ISBN: 978-1-4614-5167-9
eBook Packages: MedicineMedicine (R0)